Use our chat feature to speak with one of our expert consultants who can help you identify if medical cannabis can help you.
Get the latest Releaf Cannabis Clinic news, updates, and announcements. Stay informed about our services, events, and medical cannabis expertise.
Despite medical cannabis being legal in the UK for almost six years, there is still confusion— and mixed messages—around the rights and responsibilities of patients when it comes to driving with their prescription.
We officially launched six months ago on February 1st after almost a year of hard work and preparation. We now have over 20,000 members in our community, and thought it was time to take a trip down memory lane to see how we achieved this, what we’ve learnt along the way, and what our patients have to say.
Fibromyalgia is a chronic condition which can be hard to diagnose and hard to treat. But in many patients— and supported by a growing evidence base— medical cannabis is showing promise for symptom management and improving quality of life. We take a closer look at the research and hear from those with first-hand experience.
The UK medical cannabis sector is one of the safest and most highly regulated in the world. This is thanks to the strict procedures and guidelines put in place by regulatory bodies such as the Medicines and Healthcare product Regulatory Agency (MHRA), the Quality Care Commission (CQC), and NICE (National Institute for Health and Care Excellence). These organisations ensure that the medical cannabis products available to UK patients are safe, effective, and high quality.
Conditions that affect the gastrointestinal tract - often called gastroenterological conditions - can greatly affect an individual’s health and quality of life. Yet, despite being relatively common in the Western population, effective management of these conditions and their symptoms is often elusive. However, in recent years, emerging evidence has indicated that medical cannabis may have a role to play in reducing the burden of some of the most common gastroenterological conditions.
Every August, the National Psoriasis Foundation hosts Psoriasis Action Month - a time dedicated to raising awareness around this common disease and providing advice and support to those affected. Despite affecting an estimated 125 million people worldwide, the impact of psoriasis is still not widely understood.
Medical cannabis treatment and finding the perfect combination of cultivar (or oil) and dosage sizing is, at least in some respect, an individualised process. Some patients find the level of symptom management they are hoping for straight away, but for others, it can take a little bit of experimentation to find the balance that works best for them.
Medical cannabis has recently hit the big time here in the UK. Although it's been legal for almost six years (since November 2018), the general public's understanding of this has been surprisingly lacking. That is, until now.
From Morrisons to medical cannabis clinics, CBD seems to be everywhere – but, what actually is it? For National CBD Day, we explain the A-B-Cs of CBD, from its plant-based origin to its clinical applications – here’s everything you need to know about CBD.
Cannabis is an incredibly complex plant that contains thousands of active compounds. While the most well-known compounds may be cannabinoids - and of these, CBD and THC enjoy the most coverage - another class of compounds contribute significantly to the potential benefits of this incredible plant: Terpenes.
Storing most medications correctly is essential to not only the shelf life but also the overall efficacy. This is (debatably) even more important when it comes to dried medical cannabis flower, as it is an organic product, unlike most conventional pharmaceuticals.
Welcome to a day in the life of a Medical Cannabis Clinical Director in the UK! We spoke to our very own Dr David Tang about his role and responsibilities as Releaf’s Clinical Director to lift the curtain on what happens behind the scenes in the UK’s fastest growing medical cannabis clinic in the UK.
Every patient is unique, and so are their medical needs. As a medical cannabis clinic, having a varied formulary allows us to cater to a large cohort of patients, from those with chronic pain or insomnia, to those with anxiety and depression, or MS and Parkinson’s, and offer them each unique, individualised treatment plans.
Decisions surrounding palliative care are something that almost all of us will face at some point in our lives, whether for ourselves or for someone we care deeply about. But before that time comes, it's a subject that is often avoided or at least slightly misunderstood.
We know what a difference the right vape can make, that’s why we’ve given out over £115,000 of Omura products to medical cannabis patients in the UK for free.
Every year, the 25th of July commemorates National Schizophrenia Awareness Day - an event established by mental health charity, Rethink Mental Health. The day aims to shine a spotlight on the everyday challenges faced by the millions of people living with schizophrenia and the stigma and discrimination that still remain around this diagnosis.
In today's write-up, we will explain all the factors that can and do affect the price of medical cannabis cultivars. Here at Releaf, we want to ensure that our patients are well-informed about their medication options, including the pricing factors.
In the last two decades, global plastic production has doubled, with 400 million tonnes of plastic waste now produced every year. As one of the only UK clinics to provide medical cannabis flower in eco-friendly packaging, Releaf is committed to finding more sustainable solutions this Plastic Free July and is taking steps towards a plastic-free future.
Medical cannabis was legalised in the UK in 2018 for patients with health conditions known to respond to cannabis-based treatments, if conventional or licensed medications have failed to meet their needs. Because one of these health conditions is Multiple Sclerosis, Releaf are joining MS-UK for a free Webinar on the 21st of August, to explain how these treatments can be safely incorporated into MS treatment plans.
One month ago, we announced our first-of-its-kind partnership with Glass Pharms® - an arrangement that aims to reduce hurdles between the prescription and receipt of medical cannabis products in the UK. One month on, we have been thrilled to see how this partnership has brought medical cannabis into the mainstream news once again.
Although our phone lines are open from 9 to 5 Monday through Friday, Releaf’s Patient Support Team work tirelessly around the clock behind the scenes, to ensure we provide the most seamless, and supportive service to medical cannabis patients in the UK.
When medical cannabis was legalised in the UK in November 2018, many understandably assumed that it would be as simple to access these medications as any other prescription medicine. Unfortunately, it soon became clear that this wouldn’t be the case.
All medications come with the possibility of interactions with other drugs/pharmaceuticals, and medical cannabis is no exception. Continuing on with our 'New Patient' series, we dig our teeth into the often-asked question: "What medications interact with medical cannabis?"
Are you a medical cannabis patient in the UK that’s unhappy with the service your current clinic provides? Discover Releaf’s seamless transition process and experience UK-grown prescribed cannabis options, extensive clinical expertise, and an innovate all-in-one patient focused platform by making one simple switch.
